No one can legally or safely clone themselves today. Reproductive human cloning has never been accomplished, every country with a clear policy on the matter bans it, and the underlying technique remains so inefficient in other mammals that it would be reckless to attempt it in people. The technology that produced Dolly the sheep in 1996 has been refined over nearly three decades, yet even in well-studied animal species, the process fails far more often than it succeeds. What science has learned about cloning in that time, though, paints a fascinating and complicated picture of why self-duplication is so hard, what a clone actually is (and isn’t), and where the useful applications of this technology may actually lie.
How Animal Cloning Works and Why It Mostly Fails
The technique behind cloning is called somatic cell nuclear transfer, or SCNT. In plain terms, you take the nucleus from an ordinary body cell, like a skin cell, and insert it into an egg cell whose own nucleus has been removed. The egg’s molecular machinery then tries to “reset” the transplanted DNA back to a blank-slate embryonic state, a process researchers call reprogramming. If reprogramming works well enough, the egg develops into an embryo that can be implanted into a surrogate mother.
The problem is that reprogramming almost never works well enough. Across every mammalian species where live clones have been born, the success rate has remained stubbornly low. It is common for hundreds of reconstructed eggs to yield only a single live birth.1PubMed. The many problems of somatic cell nuclear transfer in reproductive cloning of mammals High rates of miscarriage and fetal death are the norm, and these failures trace back to the reprogramming step: the donor cell’s DNA retains chemical “marks” from its previous life as a specialized cell, and the egg cannot fully erase them.2PubMed Central. Cloning animals by somatic cell nuclear transfer–biological factors The broad consensus puts the rate of normal, viable offspring at roughly one to five percent of attempts.3PubMed Central. Lessons Learned from Somatic Cell Nuclear Transfer
The specific molecular culprit is a set of chemical modifications on histone proteins, the spool-like structures around which DNA is wound. In the donor cell, certain genes are locked down by these modifications, particularly a mark called H3K9me3. During normal fertilization, the egg strips away most of these marks so the embryo’s genome can start fresh. SCNT embryos keep too many of these marks in place, which silences genes the early embryo needs.4PubMed Central. Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation A second wave of problems shows up after implantation, when a different set of marks governing imprinting, the parent-specific silencing of certain genes, also goes awry.5PubMed. Overcoming Intrinsic H3K27me3 Imprinting Barriers Improves Post-implantation Development after Somatic Cell Nuclear Transfer Researchers have made progress by injecting enzymes that strip away these stubborn marks or by deleting certain imprinted genes in the donor cells before the transfer, but no combination of fixes has pushed success rates anywhere near those of normal reproduction.6PubMed Central. Efficient Somatic Cell Nuclear Transfer by Overcoming Both Pre- and Post-Implantation Epigenetic Barriers
Primate Cloning and What It Tells Us
For years, cloning primates proved especially difficult. That changed in 2018 when a Chinese team announced the birth of two cloned macaque monkeys, the first primates ever produced by SCNT. Their approach used a combination of an enzyme to remove the H3K9me3 mark and a drug that loosens histone packaging. Using fetal cells as the DNA source, they confirmed six pregnancies out of 21 surrogates and obtained two healthy babies. When they tried the same thing with cells from an adult monkey, they got pregnancies in 22 of 42 surrogates but the two babies born did not survive long.7PubMed. Cloning of Macaque Monkeys by Somatic Cell Nuclear Transfer The fact that fetal cells worked better than adult cells underscored a recurring theme: the older and more specialized the donor cell, the harder it is to reprogram.
A follow-up study went further, cloning five macaques from fibroblasts of a young adult monkey that had been gene-edited. Out of 325 embryos transferred into 65 surrogates, five cloned monkeys were born.8PubMed Central. Cloning of a gene-edited macaque monkey by somatic cell nuclear transfer The numbers are worth pausing on: 325 embryos, 65 surrogates, five surviving offspring. That is roughly a 1.5 percent yield at the embryo level, consistent with the overall range seen across mammalian cloning. These experiments demonstrated that primate cloning is possible, but they also showed just how resource-intensive and failure-prone the process remains when applied to species close to humans.
What Has Actually Been Done With Human Cells
No one has ever produced a cloned human baby, and no credible laboratory has claimed to try. What researchers have managed is a more limited but still important step: deriving embryonic stem cells from human SCNT embryos. In 2013, a team overcame previous roadblocks by identifying specific timing issues with human eggs during the nuclear transfer process. When they optimized these steps and used high-quality eggs, they could derive stem cell lines from as few as two eggs. These cells had normal chromosomes and behaved like embryonic stem cells derived from naturally fertilized embryos.9PubMed Central. Human embryonic stem cells derived by somatic cell nuclear transfer
This is a critical distinction. Creating stem cells from a cloned embryo is not the same as bringing a cloned embryo to term. The embryos in these experiments developed to the blastocyst stage, a hollow ball of about 100 cells that forms a few days after fertilization, and then the stem cells were harvested. No embryo was implanted in a uterus. The work showed that human eggs can reprogram adult DNA at least partway, but getting from a blastocyst to a viable nine-month pregnancy involves entirely different challenges that have never been tested and would be illegal virtually everywhere.
Why a Clone Would Not Be You
Even setting aside the legal and technical barriers, a clone produced from your cells would not be a copy of you in any meaningful everyday sense. The most common misconception about cloning is that it produces a duplicate person, identical in appearance, personality, and ability. Researchers who study identity and cloning have argued that this fear is needlessly alarmist; a cloned individual would not show the donor’s characteristics to the extent of compromising their uniqueness.10PubMed. Psychological aspects of human cloning and genetic manipulation: the identity and uniqueness of human beings Think of identical twins: they share the same nuclear DNA, grow up in the same household, and still become distinct people with different preferences, talents, and temperaments. A clone would share even less with its donor than identical twins share with each other, for several biological reasons.
First, the clone’s mitochondrial DNA would not match yours. In SCNT, the egg cell contributes its own mitochondria, the tiny power-generating structures in every cell that carry their own small genome. The donor cell’s mitochondria are almost entirely eliminated during early embryonic development, so by the blastocyst stage, the clone’s cells run on the egg donor’s mitochondrial DNA, not yours.11Journal of Animal and Feed Sciences. The role of mitochondrial genome (mtDNA) in somatic and embryo cloning of mammals. A review Studies in cloned cattle confirmed this pattern: most offspring carried only the oocyte donor’s mitochondrial type, with the donor cell’s mitochondrial DNA becoming essentially undetectable.12Journal of Reproduction and Fertility. Dominant distribution of mitochondrial DNA from recipient oocytes in bovine embryos and offspring after nuclear transfer Mitochondrial DNA makes up only a tiny fraction of total genetic information, but it influences metabolism and energy production in every cell. This means a “perfect” genetic clone, one whose total genome matches the donor in every way, is only possible if the egg comes from the same individual, something only biologically feasible for females donating their own eggs.11Journal of Animal and Feed Sciences. The role of mitochondrial genome (mtDNA) in somatic and embryo cloning of mammals. A review
Second, personality is not purely genetic. A study testing behavioral traits in groups of cloned minipigs found that even genetically identical animals raised together developed measurably different personality profiles. While some activity-level differences between clone groups appeared to have a genetic component, the researchers noted that early-life experiences and group dynamics shaped individual behavior as well.13Journal of Veterinary Behavior. Assessment of personality traits in cloned minipigs using three different behavioral tests A human clone, born decades after the donor, raised by different people in a different cultural moment, would diverge from its DNA source far more dramatically than lab-raised pigs diverge from each other.
The Health Problems That Haunt Cloned Animals
Among the animals that do survive to birth after SCNT, an alarming share suffer from a cluster of developmental problems collectively known as large offspring syndrome. In cattle and sheep, cloned offspring can weigh up to twice the normal birth weight, and they often present with organ enlargement and abdominal wall defects.14PubMed. Large offspring syndrome in ruminants: current status and prediction during pregnancy Placental abnormalities are especially common. The syndrome appears at various stages, from midway through pregnancy to after birth, and it remains one of the biggest practical obstacles to broader use of cloning in agriculture.15PubMed. Incidence of abnormal offspring from cloning and other assisted reproductive technologies
Telomere biology adds another layer of concern. Telomeres are protective caps on the ends of chromosomes that shorten with age; when they get too short, cells stop dividing normally. In some cloned cattle, telomere length was successfully “reset” during embryonic development, meaning the calves were born with telomeres comparable in length to those of naturally conceived calves of the same age.16PubMed. Reprogramming of telomerase activity and rebuilding of telomere length in cloned cattle But this reset does not always happen. A 2024 study of cloned calves that died at birth found they had significantly shortened telomeres compared to both naturally conceived calves and cloned calves that survived, along with lower levels of the enzyme responsible for maintaining telomere length.17PubMed. Impact of telomere length and mitochondrial DNA copy number variants on survival of newborn cloned calves In other words, the reprogramming process sometimes fails to reverse the biological age of the donor cell’s DNA, and the consequences can be fatal.
Applying these risks to humans would be unconscionable. A technique that routinely produces oversized fetuses, placental failure, and neonatal death in well-studied livestock species cannot ethically be tried in people. This safety profile is one of the strongest practical arguments against human reproductive cloning, separate from any moral or philosophical objection.
Where Human Cloning Is Banned
There is no single international treaty that prohibits human cloning worldwide. The United Nations debated the issue in the early 2000s but ultimately adopted a non-binding declaration in 2005 calling on member states to ban all forms of human cloning incompatible with human dignity. The declaration lacked enforcement teeth, and countries were left to write their own laws.18Law, Culture and the Humanities. Cloning International Law: The Science and Science Fiction of Human Cloning and Stem-Cell Patenting The result is a patchwork. More than 70 countries have passed laws banning reproductive cloning, including the UK, France, Germany, Japan, Australia, Canada, and Brazil. The United States has no federal ban, though several states have enacted their own prohibitions and federal funding cannot be used for human cloning research. In countries where religion heavily influences legislation, bans on reproductive cloning tend to be firm, though positions on therapeutic uses of cloned embryos vary. Islamic jurisprudence, for instance, generally prohibits reproductive cloning but permits stem cell research for therapeutic purposes under careful conditions during early embryonic stages.19Saudi Medical Journal. Human cloning, stem cell research. An Islamic perspective.
Some legal scholars have noted that these laws may eventually need updating. Advances in artificial womb technology could theoretically remove the need for a surrogate mother, altering the practical calculus of reproductive cloning even if the ethical objections remain unchanged.20BIO Web of Conferences. Human cloning, artificial wombs, and the future of Hindu succession act: Reconciling biotechnology with lineage law For now, though, the global consensus against reproductive human cloning is about as strong as any position in bioethics gets.
Therapeutic Cloning Is a Different Story
While reproductive cloning, bringing a cloned embryo to a live birth, is widely banned and far from feasible in humans, therapeutic cloning occupies different scientific and ethical ground. The goal is not to create a person but to create patient-matched stem cells that could be used to grow replacement tissue or treat genetic diseases. Because the stem cells would carry the patient’s own nuclear DNA, the body’s immune system would be less likely to reject transplanted tissue derived from them.21PubMed Central. Therapeutic cloning: promises and issues
Animal studies have shown promise for treating conditions like Parkinson’s disease, muscular dystrophy, and diabetes using cells derived from SCNT embryos.21PubMed Central. Therapeutic cloning: promises and issues The technology could also potentially be applied to growing entire organs for transplant.22PubMed Central. Cloning humans? Biological, ethical, and social considerations However, therapeutic cloning still faces opposition because it involves creating and then destroying human embryos to harvest stem cells, which some religious and ethical traditions find unacceptable regardless of the medical purpose.
In practice, much of the clinical momentum has shifted to a competing technology: induced pluripotent stem cells, or iPSCs. These are produced by taking ordinary adult cells and chemically coaxing them back into a stem-cell-like state, without any egg or embryo involved. Human iPSC lines have been derived from both healthy and diseased individuals, sidestepping the ethical and logistical challenges of SCNT.23PubMed. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells Both approaches can generate patient-specific stem cells with minimal immune rejection risk.24PubMed. Generation of Pluripotent Stem Cells Using Somatic Cell Nuclear Transfer and Induced Pluripotent Somatic Cells from African Green Monkeys
That said, SCNT-derived stem cells may still have an edge in quality. When researchers compared stem cells produced by nuclear transfer to those produced by the iPSC method, the SCNT cells resembled naturally derived embryonic stem cells much more closely. The iPSC cells carried nearly 60 times more sites where their chemical DNA markings differed from the embryonic-stem-cell benchmark, and about one in ten of those differences could be traced to leftover “memory” of the donor cell’s original identity.25STEM CELLS. Concise Review: Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer: A Horse in the Race? Whether this difference matters clinically remains an open question, but it suggests that SCNT is not obsolete as a research tool even if iPSCs have become the workhorse of regenerative medicine.
How Media and Pop Culture Distort the Picture
Public understanding of cloning is heavily shaped by science fiction and sensational media coverage, and the gap between perception and reality is enormous. Analyses of how cloning is portrayed in popular media have found that documentaries and entertainment frequently blur the line between reproductive and therapeutic cloning, or treat genetic identity as though it were the same as personal identity. The resulting impression, that a clone would be an instant adult copy of the donor, walking around with the same memories and personality, has no basis in biology but persists in the public imagination.26PubMed Central. Cloning in the media and popular culture. An analysis of German documentaries reveals beliefs and prejudices that are common elsewhere.
A real clone, if one were ever born, would be a baby. It would grow at a normal pace, learn to walk and talk on a typical developmental timeline, and form its own identity through its own experiences. It would not have the donor’s memories, skills, or accumulated knowledge. It would not even look exactly like the donor at the same age, because physical appearance is influenced by nutrition, sun exposure, illness, and countless other environmental factors. The clone’s nuclear DNA would match the donor’s, much like an identical twin’s does, but that is where the duplication ends. Even the mitochondrial DNA, as discussed earlier, would likely come from a different individual. The sci-fi fantasy of pressing a button and stepping out of a machine as two identical adults is not something cloning, or any foreseeable technology, could deliver.
This misunderstanding matters because it distorts public debate. People who believe cloning produces instant copies tend to view it as an existential threat to human individuality. People who understand that a clone is simply a delayed genetic twin are better positioned to evaluate the actual ethical questions, which center on the welfare of the resulting child, the risks of the procedure, and the moral status of embryos created and destroyed in the process. Those questions are serious and unresolved. They deserve to be debated on their own terms rather than through the lens of a movie plot.
Pet Cloning and the Commercial Reality
If human reproductive cloning is off the table, animal cloning is already a commercial service, at least for those willing to pay. Several companies offer to clone pet dogs and cats for fees in the tens of thousands of dollars. The process uses the same SCNT technique, with a skin biopsy taken from the pet (or preserved from a deceased pet), the nucleus transferred into a donor egg, and the embryo implanted into a surrogate animal. The success rates are higher than in some other species, but the procedure still requires multiple surrogates and many attempts per successful birth.
Pet cloning offers a real-world illustration of the identity gap between a clone and its genetic source. Owners who clone a beloved dog frequently report that the clone looks strikingly similar but has a noticeably different personality. Coat color markings can even differ because some pigmentation patterns are influenced by random developmental events in the womb rather than strict genetic instructions. The experience has been described by some owners as getting a relative of their old pet rather than their old pet back, a living reminder that DNA is a recipe, not a blueprint, and the final product depends on the kitchen as much as the cookbook.
The ethics of pet cloning itself are debated. Critics point to the welfare costs for the surrogate animals and the egg donors, the high failure rates, and the uncomfortable reality that cloning a pet does nothing for the millions of animals in shelters. Supporters argue that it is a legitimate use of private resources and that the technology, refined through commercial use, could eventually benefit endangered species conservation. Either way, pet cloning serves as the closest thing to a consumer-facing demonstration of what cloning can and cannot do, making it a useful reference point for anyone wondering what “cloning yourself” would actually mean in practice.